Metrus, MDFact checked by Nick BlackmerA brain tumor can be diagnosed using imaging tests that view the structure of the brain, along with a biopsy, which can carefully assess a sample of a suspected ...

The efficacy seen in a small study, especially in GNAS-mutated tumors, could influence care, but the rarity of the cancer is ...

stabilized tumor growth and reduced blood tumor marker levels in patients with peritoneal mucinous carcinomatosis (PMC). This form of cancer originates in the appendix and is often resistant to ...

Researchers at University of California San Diego School of Medicine found an FDA-approved drug used to treat breast cancer ...

More information: Jonathan Weitz et al, Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations, Journal of Clinical Oncology (2024).

CDK4/6 inhibitor palbociclib (Ibrance) may be effective for patients with peritoneal mucinous carcinomatosis characterized by GNAS mutations, a small study indicated. (Journal of Clinical Oncology ...

Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia We enrolled 16 patients ...

stabilized tumor growth and reduced blood tumor marker levels in patients with peritoneal mucinous carcinomatosis (PMC). This form of cancer originates in the appendix and is often resistant to ...

Generalised eruptive keratoacanthoma of Grzybowski (GEKA) is a rare disease characterised by the sudden appearance of ...

We enrolled 16 patients with PMC in a single-arm personalized cancer therapy trial. For all patients, tumor tissue and/or circulating tumor DNA genomic profiling using next-generation sequencing and, ...

ARP Atlases. 2007;1:17-47. The total number of leukocytes recovered by lavage is determined by examination of a sample of the pooled fluid with a hemocytometer. The cell counts are most accurate ...